buprenorphine and Hallucinations

buprenorphine has been researched along with Hallucinations* in 4 studies

Trials

1 trial(s) available for buprenorphine and Hallucinations

ArticleYear
Antipsychotic effect of buprenorphine in schizophrenia.
    The American journal of psychiatry, 1987, Volume: 144, Issue:10

    The antipsychotic potency of the partial opiate agonist buprenorphine was evaluated in 10 neuroleptic-free schizophrenic patients suffering from frequent hallucinations, delusions, and severe formal thought disorders. Buprenorphine had a pronounced antipsychotic effect, which lasted about 4 hours, in patients with schizophreniform disorders (N = 4) and paranoid schizophrenia (N = 3).

    Topics: Adult; Buprenorphine; Clinical Trials as Topic; Delusions; Double-Blind Method; Female; Hallucinations; Humans; Male; Psychotic Disorders; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology

1987

Other Studies

3 other study(ies) available for buprenorphine and Hallucinations

ArticleYear
A case of topical opioid-induced delirium mistaken as behavioural and psychological symptoms of dementia in demented state.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2013, Volume: 13, Issue:2

    In Japan, indications for opioid analgesics, once exclusively used as pain killers for patients suffering from malignant cancer, have been expanded for a wide range of pain. Herein we report a patient with opioid-induced delirium associated with the administration of buprenorphine patches that was well below the indicated therapeutic range limit. An 82-year-old woman was referred to us from an orthopaedic practitioner for uncontrollable behavioural problems apparently caused by the beginning of dementia; the patient had gradually developed disorientation, visual hallucinations, and delusions. Laboratory and imaging findings excluded common causes of delirium including Alzheimer's disease and diffuse Lewy body disease. Detailed questioning revealed that the patient's confused state appeared following a buprenorphine patch dose increase and subsequently disappeared after administration was stopped. Delirium has not been reported as a side-effect in clinical trials of buprenorphine patches. However, our findings in this case show that even topical opioids can precipitate the development of a delirious state in elderly patients.

    Topics: Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Confusion; Delirium; Dementia; Female; Hallucinations; Humans; Japan; Low Back Pain; Transdermal Patch; Treatment Outcome

2013
Hallucinations after epidural buprenorphine.
    BMJ (Clinical research ed.), 1989, Apr-08, Volume: 298, Issue:6678

    Topics: Adult; Buprenorphine; Female; Hallucinations; Humans; Injections, Epidural; Middle Aged

1989
Near fatal auditory hallucinations after buprenorphine.
    British medical journal (Clinical research ed.), 1988, Jan-16, Volume: 296, Issue:6616

    Topics: Auditory Perception; Buprenorphine; Hallucinations; Humans; Male; Middle Aged

1988